ARKG Holdings of Incyte Corporation (INCY) - Updated Daily
Join Premium Plan
Key Statistics
Statistics
Clinical Trials (168)
Institutional Ownership Trends
News That Matters
๐ต๐ผFound In | ๐ทLast Price |
---|---|
ARKG | $77.10 |
โ๏ธWeighting | ๐งขMarket Cap |
2.66% | $17.06b |
๐๐ฟโโ๏ธWeight Rank In ARKG | ๐งฎPrice to Sales |
15 | 5.71 |
๐๏ธโโ๏ธWeight Rank Across All Funds | ๐Country |
43 | ๐บ๐ธUnited States |
๐ณARK Estimated Cost Average | ๐ซARK Ownership Percent |
$90.54 | 0.57% |
Description | |
---|---|
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. | |
Website | |
www.incyte.com |
Research Notes and Commentary for INCY
No Research Notes Found for INCY